Formulate, batch,
and prove it.
The process-manufacturing pack and the regulatory hub, for formulation and nutraceutical manufacturers. Recipes and batch genealogy, stability and shelf life, lab certificates, and adverse-event reporting with formal causality assessment.
An industry accelerator on the Prabandh platform — the same ERP, PLM, CRM and QMS core every other industry runs on.
The problem
You run regulated process manufacturing and need the core before the specialisation.
Most pharma software is bought for the specialisation and lived in for the basics.
Batch genealogy, stability, lab results and a regulatory register are what the working week actually consists of — and they are the parts most often bolted onto an ERP that was never designed for them. Prabandh serves this as the process-manufacturing pack plus the regulatory hub.
You will recognise these
- Batch records and the financial system are two different worlds
- Stability and shelf-life data sit outside the batch that produced them
- The regulatory calendar is owned by a person, not a system
- Lab results are transcribed rather than captured
What it costs when it goes wrong
Regulated manufacturing tolerates gaps in evidence badly. The exposure is not a fine — it is a hold on product you have already made.
How Prabandh fixes it
- 01
Process manufacturing on the shared core
Formulations and recipes, batch genealogy, lab results and certificates of analysis, and shelf-life and stability — the process pack, on the same ledger and inventory as the rest of the business.
- 02
A regulatory hub that is a register, not a reminder
Obligations, audits, nonconformances and licence expiry as records with states, so what is overdue is a query rather than a recollection.
- 03
Quality on the same spine
Control plans, inspection lots with sampling, nonconformance and CAPA, and SPC — attached to the product they govern rather than kept beside it.
What changes
A working core you can operate on from day one — and an explicit conversation about what a pharma-specific build would add, rather than a demo of screens that do not exist yet.
Six capabilities you would otherwise build yourself.
Everything below is on top of the shared core — not instead of it.
Formulations & Recipes
Formulation master with scaling, sub-recipes and cost roll-up, resolving to the input lots actually consumed.
Batch Genealogy
Backward to every raw-material lot and forward to every consignment — the two directions a recall or a deviation investigation runs in.
Stability & Shelf Life
Shelf-life rules with FEFO enforcement at picking, so stock that would expire in transit does not ship.
Lab & Certificate of Analysis
Test definitions, recorded results and a CoA generated from them rather than typed alongside them.
Pharmacovigilance
Adverse events with WHO-UMC and Naranjo causality assessment and PvPI submission — a structured framework, not a free-text complaint log.
Quality Management
Control plans, inspection lots with sampling, nonconformance and CAPA, SPC and gage calibration — shared with every other industry on the platform.
Eight integrated modules. One login.
Formulations
Recipe master with scaling and cost roll-up.
Batch Genealogy
Two-way traceability through production.
Shelf Life & Stability
Expiry rules and FEFO enforcement.
Lab & CoA
Test results and certificate generation.
Pharmacovigilance
Adverse events with causality assessment.
Licensing
Licence register with expiry alerts.
QMS
Control plans, inspection, CAPA, SPC, calibration.
ERP Core
GST invoicing, inventory, purchase, accounting and payroll.
The frameworks this industry is audited against.
This is the process-manufacturing and regulatory capability a formulation maker runs on. Allopathic-specific screens — generics master, prescription schedule — are on the roadmap, not shipped, and we will say so in the demo.
A capability built for one reaches the rest.
The lifecycle freeze protecting a released drawing is the same one protecting an issued tech pack. The batch genealogy behind a food recall is the same engine behind fibre supplier-lot traceability.
Where we stop today
The honest boundary for pharma & life sciences, so you hear it here rather than three weeks into an evaluation. Everything above is built and reachable; everything below is not.
- Revised Schedule M readiness — the gap assessment and its documentation set are not built.
- 21 CFR Part 11 / EU Annex 11 electronic signatures are not implemented, and the system is not validated to them. The audit trail is immutable under Companies Act Rule 11(g), which is a different obligation.
- Allopathic-specific masters — generics, prescription schedules, drug licence categories — are on the roadmap, not shipped.
Several of these are scoped and buildable on the shared core — ask, and we will tell you what it would take rather than whether it is “on the roadmap”.
Ready to run pharma on one system?
See the Pharma & Life Sciences accelerator in 30 minutes — we walk your own process, not a generic demo script.